These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 947967)

  • 21. Furosemide binding to human albumin and plasma of nephrotic children.
    Prandota J; Pruitt AW
    Clin Pharmacol Ther; 1975 Feb; 17(2):159-65. PubMed ID: 235396
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative contribution of endogenous compounds and hypoalbuminemia in reducing the binding of furosemide in the plasma of newborn infants.
    Viani A; Pacifici GM
    Dev Pharmacol Ther; 1992; 18(1-2):39-43. PubMed ID: 1483361
    [TBL] [Abstract][Full Text] [Related]  

  • 23. On the interaction of diazepam with human, rat and mouse plasma proteins and erythrocytes.
    Láznícek M; Lamka J; Kvĕtina J
    Biochem Pharmacol; 1982 Apr; 31(7):1455-8. PubMed ID: 7092935
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acetaldehyde adducts with serum proteins: effect on diazepam and phenytoin binding.
    Lucas D; Ménez JF; Daniel JY; Bardou LG; Floch HH
    Pharmacology; 1986; 32(3):134-40. PubMed ID: 3960964
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Variations in drug free fraction during alcohol withdrawal.
    Sandor P; Naranjo CA; Khouw V; Sellers EM
    Br J Clin Pharmacol; 1983 Apr; 15(4):481-6. PubMed ID: 6849785
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Co-regulation of phenytoin and tolbutamide metabolism in humans.
    Tassaneeyakul W; Veronese ME; Birkett DJ; Doecke CJ; McManus ME; Sansom LN; Miners JO
    Br J Clin Pharmacol; 1992 Dec; 34(6):494-8. PubMed ID: 1493081
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The efficacy of oral tolbutamide in chronic alcoholics.
    Horowitz SH; Johnson BF
    Am J Med Sci; 1972 Nov; 264(5):395-400. PubMed ID: 4650130
    [No Abstract]   [Full Text] [Related]  

  • 28. Serum protein binding of tolbutamide in patients treated with antiepileptic drugs.
    Fernández MC; Erill S; Lucena MI; Pita E; Pérez-Alférez N
    Clin Pharmacokinet; 1985; 10(5):451-5. PubMed ID: 3930124
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of peritoneal dialysis of tolbutamide in rats under conditions of the plasma unbound fraction being increased.
    Makita T; Aiba T; Izuwa Y; Komori Y; Kawasaki H; Kurosaki Y
    Biopharm Drug Dispos; 2009 Jan; 30(1):1-8. PubMed ID: 19148953
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tenidap sodium does not alter the clearance or plasma protein binding of tolbutamide in healthy male volunteers.
    Wilner KD; Gardner MJ
    Br J Clin Pharmacol; 1995; 39 Suppl 1(Suppl 1):39S-42S. PubMed ID: 7547093
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Binding characteristics of KNI-272 to plasma proteins, a new potent tripeptide HIV protease inhibitor.
    Kiriyama A; Nishiura T; Ishino M; Yamamoto Y; Ogita I; Kiso Y; Takada K
    Biopharm Drug Dispos; 1996 Dec; 17(9):739-51. PubMed ID: 8968527
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Displacement of tolbutamide, glibencalmide and chlorpropamide from serum albumin by anionic drugs.
    Brown KF; Crooks MJ
    Biochem Pharmacol; 1976 May; 25(10):1175-8. PubMed ID: 820348
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of pirprofen on protein binding of warfarin and tolbutamide in human plasma.
    Luders RC; Chao D
    J Pharm Sci; 1981 Dec; 70(12):1370-1. PubMed ID: 7320855
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug-binding and other physicochemical properties of a large tryptic and a large peptic fragment of human serum albumin.
    Bos OJ; Fischer MJ; Wilting J; Janssen LH
    Biochim Biophys Acta; 1988 Mar; 953(1):37-47. PubMed ID: 3124878
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduced concentrations of plasma diazepam in chronic alcoholic patients following an oral administration of diazepam.
    Sellman R; Pekkarinen A; Kangas L; Raijola E
    Acta Pharmacol Toxicol (Copenh); 1975 Jan; 36(1):25-32. PubMed ID: 1173720
    [No Abstract]   [Full Text] [Related]  

  • 36. Altered plasma drug binding in cancer: role of alpha 1-acid glycoprotein and albumin.
    Jackson PR; Tucker GT; Woods HF
    Clin Pharmacol Ther; 1982 Sep; 32(3):295-302. PubMed ID: 7105620
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of albumin conformation in the binding of diazepam to human serum albumin.
    Wilting J; Hart BJ; De Gier JJ
    Biochim Biophys Acta; 1980 Dec; 626(2):291-8. PubMed ID: 7213648
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interactions of sulfonylureas with plasma proteins.
    Hsu PL; Ma JK; Luzzi LA
    J Pharm Sci; 1974 Apr; 63(4):570-3. PubMed ID: 4208196
    [No Abstract]   [Full Text] [Related]  

  • 39. Delta5-androstenediol: kinetics of metabolism and binding to plasma proteins in normal men and women.
    Bird CE; Morrow L; Fukumoto Y; Marcellus S; Clark AF
    J Clin Endocrinol Metab; 1976 Dec; 43(6):1317-22. PubMed ID: 63469
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics of diazepam in the rat: influence of a carbon tetrachloride-induced hepatic injury.
    Díaz-García JM; Oliver-Botana J; Fos-Galve D
    J Pharm Sci; 1992 Aug; 81(8):768-72. PubMed ID: 1403721
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.